Feature Latest Stories
Mark Socinski, MD; Mary Jo Fidler, MD; Roy Herbst, MD, PhD; Geoffrey Oxnard, MD; and Naiyer Rizvi, MD discuss the potential for checkpoint inhibitors, such as pembrolizumab, for malignant mesothelioma. Also discussed is the importance of trials that can be done in the community setting. View Now >>
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Shreyaskumar Patel, MD; Lor Randall, MD, FACS; Jonathan Trent, MD, PhD; and Andrew Wagner, MD, PhD, highlight some of the key members of their multidisciplinary teams who are sometimes overlooked. View Now >>
Laura Jones recaps major findings from the 2015 ASCO Annual Meeting, including phase III findings for new treatments in melanoma, chronic lymphocytic leukemia, lung cancer, breast cancer, and multiple myeloma.
Most Popular Right Now